Skip to main content
. 2016 Sep 12;2016(9):CD011567. doi: 10.1002/14651858.CD011567.pub2

Comparison 3. SSRIs versus benzodiazepines.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Failure to respond 1 154 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.48, 1.80]
1.1 Paroxetine versus BDZs 1 154 Risk Ratio (M‐H, Random, 95% CI) 0.93 [0.48, 1.80]
2 Total number of dropouts 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.71 [1.03, 2.84]
2.1 Paroxetine versus BDZs 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.71 [1.03, 2.84]
3 Failure to remit 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.12 [0.79, 1.59]
3.1 Paroxetine versus BDZs 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.12 [0.79, 1.59]
4 Panic symptoms 1 146 Mean Difference (IV, Random, 95% CI) 0.10 [‐0.34, 0.54]
4.1 Paroxetine versus BDZs 1 146 Mean Difference (IV, Random, 95% CI) 0.10 [‐0.34, 0.54]
5 Frequency of panic attacks 1 137 Mean Difference (IV, Random, 95% CI) 1.20 [‐3.31, 5.71]
5.1 Paroxetine versus BDZs 1 137 Mean Difference (IV, Random, 95% CI) 1.20 [‐3.31, 5.71]
6 Agoraphobia 1 112 Std. Mean Difference (IV, Random, 95% CI) 0.0 [‐0.37, 0.37]
6.1 Paroxetine versus BDZs 1 112 Std. Mean Difference (IV, Random, 95% CI) 0.0 [‐0.37, 0.37]
7 General anxiety 1 127 Mean Difference (IV, Random, 95% CI) ‐0.60 [‐3.35, 2.15]
7.1 Paroxetine versus BDZs 1 127 Mean Difference (IV, Random, 95% CI) ‐0.60 [‐3.35, 2.15]
8 Depression 1 127 Mean Difference (IV, Random, 95% CI) ‐3.60 [‐6.36, ‐0.84]
8.1 Paroxetine versus BDZs 1 127 Mean Difference (IV, Random, 95% CI) ‐3.60 [‐6.36, ‐0.84]
9 Social functioning 1 125 Mean Difference (IV, Random, 95% CI) ‐3.40 [‐8.81, 2.01]
9.1 Paroxetine versus BDZs 1 125 Mean Difference (IV, Random, 95% CI) ‐3.40 [‐8.81, 2.01]
10 Quality of life 0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
11 Patient satisfaction 0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
12 Economic costs 0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
13 Number of dropouts due to adverse effects 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.2 [0.55, 2.61]
13.1 Paroxetine versus BDZs 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.2 [0.55, 2.61]
14 Number of patients experiencing at least one adverse effect 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.03 [0.92, 1.15]
14.1 Paroxetine versus BDZs 1 154 Risk Ratio (M‐H, Random, 95% CI) 1.03 [0.92, 1.15]